Galera claims positive update in pancreatic cancer but doesn't report p-values

Malvern, PA-based Galera Therapeutics released updated follow-up data Wednesday afternoon for a Phase I/II trial in pancreatic cancer, though it did not reveal any p-values associated with the results.